Earnings NewsHealthcareEpizyme beats by $0.10, beats on revenueAug. 13, 2014 7:34 AM ETIpsen S.A. (IPSEY) StockBy: SA News Team Epizyme (NASDAQ:EPZM): Q2 EPS of -$0.40 beats by $0.10. Revenue of $9.5M (-36.0% Y/Y) beats by $1.92M. Press Release Recommended For YouMore Trending NewsSee More »About IPSEY StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgIPSEY--Ipsen S.A.Trending AnalysisTrending News